New York – Page 42

With Insider Help, Ra Pharma Upsizes IPO, Bags $92M

The IPO market has been much more discerning about biotechs in 2016 than it was during the 2013-2015 boom. But Wall Street investors embraced Ra Pharmaceuticals Tuesday evening, enabling the Cambridge, MA-based company to close an even bigger IPO than it had hoped for. Ra raised close to $92 million in the offering. The company … Continue reading “With Insider Help, Ra Pharma Upsizes IPO, Bags $92M”

Latest Data Show Venture Capital Industry on Pins and Needles

Given the obvious anxiety and frustration that surrounds us all, the U.S. venture industry is also exhibiting some fatigue as we finish the 88th month since the last recession. This is the fourth-longest period of economic growth in U.S. history (admittedly, at 2.1 percent, the growth over this period of time is the slowest since … Continue reading “Latest Data Show Venture Capital Industry on Pins and Needles”

Houston SheHacks Event Encourages Women to Form, Lead Tech Startups

Houston—Rebellion Photonics co-founder and CEO Allison Lami Sawyer said she’s tired of being alone when attending technology conferences full of men. “Where is the pipeline of women behind me?” she said. “I want to see more women CEOs.” Sawyer’s remarks on Sunday were given to an assembled crowd attending SheHacks, a hackathon geared towards women … Continue reading “Houston SheHacks Event Encourages Women to Form, Lead Tech Startups”

FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer

The FDA has approved the use of pembrolizumab (Keytruda) for some previously untreated patients with a certain type of lung cancer, the drug’s owner Merck (NYSE: [[ticker:MRK]]) announced late Monday. Pembrolizumab can now be used for patients who have never received treatment for non-small cell lung cancer (NSCLC) that has spread to other parts of … Continue reading “FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer”

Why Friday’s Massive DDoS Attack Should Be Terrifying

Friday’s massive DDoS attack made a number of hugely popular websites unavailable for much of the country for large parts of the day. Our service wasn’t directly affected by this incident, but the nature and scope of this attack is tremendously worrisome. In a Denial of Service (DoS) attack, the perpetrator overwhelms a target company … Continue reading “Why Friday’s Massive DDoS Attack Should Be Terrifying”

Safety Issue Triggers Partial FDA Hold for Aduro Bio

Aduro Biotech ran into some trouble earlier this year when one of its cancer immunotherapies failed a clinical trial. Now the Berkeley, CA, company has a safety problem and a clinical trial delay to deal with. Aduro (NASDAQ: [[ticker:ADRO]]) said this morning that one of the patients in its ongoing clinical trials of CRS-207, a … Continue reading “Safety Issue Triggers Partial FDA Hold for Aduro Bio”

Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo

If you’re among those frustrated by the lack of talk about health and science in the three presidential debates, this week perhaps brought you a wee consolation prize. The steady drip of hacked Hillary Clinton-related emails showed her campaign team questioning then-candidate FDA commissioner Robert Califf’s ties to the pharma industry. The staff also crowed … Continue reading “Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo”

Ticket Evolution Lands $2,000,002 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=484d7122-d3e3-4895-a092-7aa7d60015f3 Date 10/21/2016 Company Name Ticket Evolution Mailing Address 110 W 30th St. 7th Floor New York, NY 10001 USA Company Description Ticket Evolution has quickly become one of the most recognized names in the secondary ticket industry. As the only ticket broker owned platform currently operating in this niche, Ticket Evolution … Continue reading “Ticket Evolution Lands $2,000,002 New Financing Round”

BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders

For three years, a group of investors and experienced neuroscience executives have been stealthily advancing one of the more ambitious new startups in neurology, called BlackThorn Therapeutics. Today they’re finally shedding a little light on what they’ve been up to. As Xconomy reported last year, South San Francisco, CA-based BlackThorn was spun out of Scripps … Continue reading “BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders”

All In One Place: A New Immuno-Oncology Trial Resource

More than 100 years ago, New York bone surgeon William Coley began to suspect that bacterial infections might be improving the outlook for patients also suffering from cancer. The infections were turbo-charging the immune system. Coley (pictured) would be gratified to see that in 2016 a growing array of immune-boosting cancer treatments are helping some … Continue reading “All In One Place: A New Immuno-Oncology Trial Resource”

At NY Life Sci 2021, Yancopoulos, Dunn & More to Ponder NYC’s Bio Future

Five years is a long time. But in New York biotech it might as well be a century given how fast things are changing. Back in 2011, Xconomy held an event called New York Life Sciences 2031. In light of a major initiative by city, university, and industry leaders to spur the local life sciences … Continue reading “At NY Life Sci 2021, Yancopoulos, Dunn & More to Ponder NYC’s Bio Future”

Xconomy’s EXOME Presents: New York Life Sciences 2021

Five years ago, in light of a major initiative by city, university, and industry leaders to spur growth in the local biotech cluster, Xconomy held an event called New York Life Sciences 2031. The idea was to look out 20 years to envision the changes the new efforts might bring. Few imagined things would have … Continue reading “Xconomy’s EXOME Presents: New York Life Sciences 2021”

The Power of the Cloud for Life Science R&D

“In the new world, it is not the big fish which eats the small fish, it’s the fast fish which eats the slow fish…” — Klaus Schwab, Founder/Executive Chairman, World Economic Forum Over the past decade, the nature of innovation has changed—even as the pace has substantially increased. One of the reasons has been the ability … Continue reading “The Power of the Cloud for Life Science R&D”

After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes?

Five years ago, in November 2011, a company from Princeton, NJ, called Pharmasset shared news that would have an impact on millions of people around the world with hepatitis C. Its experimental drug PSI-7977 had quickly cleared the virus from 40 patients, with minimal side effects, and they had stayed infection-free. If the data held … Continue reading “After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes?”

The Inevitability and Necessity of the New York Tech Community

Curiosity and opportunity led me to cover the New York startup scene for Xconomy, first as a correspondent and then for the past three and a half years as the local editor. Much like the companies I watched grow, evolve, and exit, I will be moving on. New York is a city of change—an ongoing … Continue reading “The Inevitability and Necessity of the New York Tech Community”

CloudLex Obtains $3,700,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=029bb0f8-fdc1-4a6f-b28c-cad9d29e07d9 Date 10/18/2016 Company Name CloudLex Mailing Address 31 East 32nd Street New York, NY 10016 USA Company Description CloudLex intimately understands litigation and the needs of trial lawyers. CloudLex is designed by experienced attorneys, industry professionals and expert engineers, with significant experience mapping, managing and processing litigation matters. Website http://www.cloudlex.com Transaction … Continue reading “CloudLex Obtains $3,700,000 Series A Funding Round”

Early Data for Celgene’s Oral Crohn’s Drug Gets Mixed Reaction

Celgene late Sunday provided more details on one of the more important drugs in its pipeline, a pill the Summit, NJ, company is developing for inflammatory bowel disease. Analysts on Wall Street are mixed on the clinical results. The data, which Celgene is presenting at United European Gastroenterology Week in Vienna, Austria, are an early … Continue reading “Early Data for Celgene’s Oral Crohn’s Drug Gets Mixed Reaction”

Weeks After Deal, FDA Slaps Clinical Hold on Regeneron/Teva Pain Drug

Regeneron Pharmaceuticals has seen its share of ups and downs over the years developing a drug for chronic pain that could represent an alternative to addictive opioids. And another roadblock just emerged this morning. Regeneron (NASDAQ: [[ticker:REGN]]) and partner Teva Pharmaceutical Industries (NYSE: [[ticker:TEVA]]) said this morning that safety issues have prompted the FDA to … Continue reading “Weeks After Deal, FDA Slaps Clinical Hold on Regeneron/Teva Pain Drug”

Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs

For close to a decade, Tom Daniel and George Golumbeski comprised perhaps one of the best-known dealmaking duos in biopharma, striking a slew of alliances that established Summit, NJ-based Celgene as one of the more creative, nimble biotech partners in the business. “We think alike,” Daniel says. “We can pretty much finish each other’s sentences.” … Continue reading “Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs”

DataKind Obtains $2,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8b270126-def8-4994-9362-63e5eeed73bb Date 10/17/2016 Company Name DataKind Mailing Address 156 5th Avenue New York, NY 10010 USA Company Description DataKind harnesses the power of data science in the service of humanity by engaging data science and social sector experts on projects addressing critical humanitarian problems and by leading the conversation about how data … Continue reading “DataKind Obtains $2,000,000 New Round”

HyPR Lands $3,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=324e03a2-1bee-4b8d-b4ab-7f92fc369fb6 Date 10/17/2016 Company Name HyPR Mailing Address 7 World Trade Center 10th Floor New York, NY 11000 USA Company Description HYPR is revolutionizing influencer marketing by providing clients with in-depth audience demographics of social influencers. Website http://www.hyprbrands.com Transaction Type Venture Equity Transaction Amount $3,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes … Continue reading “HyPR Lands $3,000,000 New Funding Round”

Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More

On Aug. 4, shares of Bristol-Myers Squibb closed at $75.32. Today, shares are worth just over $50. That means in three months, Bristol has lost a third of its value, equivalent to about $40 billion in market capitalization. The reason? One failed clinical trial has left rival Merck in the lead position to have what … Continue reading “Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More”

PlaceIQ Obtains $25,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8916f632-70cd-408f-af62-0cae72117694 Date 10/14/2016 Company Name PlaceIQ Mailing Address 5 Bryant Park 1065 6th Ave. 18th Floor New York, NY 10018 USA Company Description PlaceIQ is able to take large amounts of often unstructured, unrelated, location based data such as photos, place data, event data, digital and social data (and much, much more) … Continue reading “PlaceIQ Obtains $25,000,000 New Funding Round”

TouchBistro Receives $13,000,000 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=30236c88-e1d6-430d-84d6-4ceacc99970c Date 10/14/2016 Company Name TouchBistro Mailing Address 5 West 20th Street 3rd Floor New York, NY 10011 USA Company Description TouchBistro is a breakthrough product for the restaurant industry. Instead of servers repeatedly moving between customers and terminals for order management, servers can remain with customers and instantly submit orders to … Continue reading “TouchBistro Receives $13,000,000 Series B Financing”

Brami Obtains $1,500,000 Seed Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=39959c7f-b3f3-4a1c-a9ec-f25af470082d Date 10/14/2016 Company Name Brami Mailing Address Undisclosed New York, NY 10956 USA Company Description The legend of BRAMI dates back to the Ancient Egyptians Pharaohs, who brought lupini seeds with them in their tombs to the afterlife. But it was the Roman Empire that truly harnessed the power of lupini. … Continue reading “Brami Obtains $1,500,000 Seed Round”

Iora Health Dials Up $75M to Expand Primary Care Clinics

[Updated 10/13/16, 5:33 pm, with CEO comments at end of story.] Investors just pumped $75 million into Iora Health in a fresh round aimed at helping the Boston-based startup expand its primary care practices to more locations and improve the software that helps run them. The Series D round announced today was led by Singapore-based … Continue reading “Iora Health Dials Up $75M to Expand Primary Care Clinics”

Ocular Therapeutix Inks Licensing Deal With Regeneron For Wet AMD

Ocular Therapeutix announced a deal this morning with Regeneron Pharmaceuticals to develop a sustained-release form of aflibercept (Eylea), Regeneron’s drug for the “wet” form of age-related macular degeneration. Tarrytown, NY-based Regeneron (NASDAQ: [[ticker:REGN]]) would pay $10 million to Ocular if it exercises an option to the experimental product. Ocular would be responsible for early stage development of … Continue reading “Ocular Therapeutix Inks Licensing Deal With Regeneron For Wet AMD”

Cloud9 Technologies Lands $30,000,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=97e86158-3736-4398-a0c8-3bb6f4068b6f Date 10/13/2016 Company Name Cloud9 Technologies Mailing Address 565 5th Avenue New York, NY 10017 USA Company Description Cloud 9 Technologies is a cloud communications service provider. We provide high performance voice, messaging and collaboration services designed for the unique needs of distributed work groups and teams. We deliver our services … Continue reading “Cloud9 Technologies Lands $30,000,000 New Financing”

WeWork Lands $260,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d15185f9-d6fd-4844-a54c-4fb412856a0d Date 10/13/2016 Company Name WeWork Mailing Address 115 W 18th St. 4th Floor New York, NY 10011 USA Company Description WeWork members are incredibly diverse, ranging from the startup, freelancer, and artist to the small business and large multinational. One thing we all share is an entrepreneurial spirit and desire to … Continue reading “WeWork Lands $260,000,000 New Funding”

Life Science Leaders Who Feel the Right Kind of Fear

In the world of betting on the future, life sciences find themselves in a storm, with huge opportunities, like CRISPR gene editing, and immense obstacles, such as soaring drug prices, that call for leaders of extra intensity who are imbued with a sense of crisis. Most people agree that the life sciences today, more than … Continue reading “Life Science Leaders Who Feel the Right Kind of Fear”

How Doctors Think About Drug Prices

There are a lot of factors involved in drug pricing that don’t enter my head when I’m seeing a patient. The three letters “PBM,” for example (pharmacy benefit manager), have never crossed my mind when I’m writing a prescription. Nor has the word “rebate.” Or the phrase “pay for delay.” Or “marketing exclusivity.” Basically, I … Continue reading “How Doctors Think About Drug Prices”

Checkpoints In Lung Cancer, and Other Oncology News From Europe

The European Society for Medical Oncology’s annual conference wraps up in Copenhagen today. We’ve seen updates on heavyweight immunotherapy programs, potential options for patients with advanced breast cancer, and more. Here’s a quick roundup of the major news. LUNG CHECKS ESMO provided more evidence that the treatment of lung cancer is changing fast. Going into … Continue reading “Checkpoints In Lung Cancer, and Other Oncology News From Europe”

The Night Scott Heiferman Almost Smashed a Watermelon at NYTM

When the CEO of Meetup took the stage last week at the latest New York Tech Meetup (NYTM), there was a touch of expectation that something eye-opening might happen. Several years prior, Scott Heiferman—who is also the co-founder of NYTM—infamously took a sledgehammer to a new Apple iPad in order to call attention to changes … Continue reading “The Night Scott Heiferman Almost Smashed a Watermelon at NYTM”

WorkRails Receives $2,300,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f14d7dbe-4b6c-472d-a436-52b4aeebe520 Date 10/10/2016 Company Name WorkRails Mailing Address Undisclosed New York, NY 11101 USA Company Description Our team sees opportunity in between the fabric that layers into our world. We love discussing what’s possible and designing solutions to problems that impact millions of people. It’s hard work and start-ups aren’t for everyone. … Continue reading “WorkRails Receives $2,300,000 New Financing”

Defying Patient Pressure, Anthem Says No to Sarepta’s Duchenne Drug

A few weeks ago, Xconomy spoke with analysts and patient advocates who considered it unlikely that insurers would balk at a potential price of $300,000 a year for eteplirsen (Exondys 51), the first approved drug for Duchenne muscular dystrophy. That’s largely been the case so far, but today a significant outlier emerged—Anthem, one of the … Continue reading “Defying Patient Pressure, Anthem Says No to Sarepta’s Duchenne Drug”

How Augmented Reality Is Transforming the Manufacturing Industry

For many Americans, the manufacturing industry brings to mind images of Industrial Revolution-era factories, World War II assembly lines, or perhaps even outsourced workshops overseas. But that picture is outdated. The truth is that the advanced technologies that are changing modern life are also revolutionizing the manufacturing industry in ways that are not yet widely … Continue reading “How Augmented Reality Is Transforming the Manufacturing Industry”

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

[Updated, 11:50 a.m. ET, see below] With the Caribbean and now the southeast U.S. coast bearing the brunt of Hurricane Matthew, we send our thoughts and more to those who have more pressing matters to worry about this week. But the show must go on. The biotech industry saw its own storms pass through, with … Continue reading “Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More”

BotFactory Obtains $1,300,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=724ebf39-c4f3-470b-9f6c-3b0d383af2fa Date 10/7/2016 Company Name BotFactory Mailing Address 29-10 Thomson Avenue 7th Floor Long Island City, NY 11101 USA Company Description BotFactory brings the future of electronic circuit fabrication to your desktop with the introduction of Squink. Just like a 3D Printer, our small circuit printer allows you to prototype in minutes … Continue reading “BotFactory Obtains $1,300,000 New Funding Round”

Goby Receives New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cdfff3e7-476a-42ea-895a-80657eca5fa9 Date 10/7/2016 Company Name Goby Mailing Address 35 East Broadway New York, NY 10002 USA Company Description We’re on a mission to make great oral care accessible to all. By partnering with the manufacturer and selling directly to you, we eliminate markups and are able to offer premium oral care products … Continue reading “Goby Receives New Financing”

Code Climate Secures $4,500,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=966d5e4c-da86-4324-9547-fc7a3f89b5b7 Date 10/7/2016 Company Name Code Climate Mailing Address 110 East 28th Street New York, NY 10016 USA Company Description Automated code review for test coverage, complexity, duplication, security, style, and more. Website http://www.codeclimate.com Transaction Type Venture Equity Transaction Amount $4,500,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. … Continue reading “Code Climate Secures $4,500,000 Series A Funding Round”

Intellia Execs Talk CRISPR’s Path Forward at Xconomy’s Oct. 20 Event

Earlier this year, Intellia Therapeutics became the second drugmaker using the landmark gene editing technology CRISPR-Cas9 to go public, after Editas Medicine. A third, CRISPR Therapeutics, could be on the way soon. Now comes the hard part. Getting past the hype and making safe, effective medicines. Over the past few decades, new drugmaking methods like … Continue reading “Intellia Execs Talk CRISPR’s Path Forward at Xconomy’s Oct. 20 Event”

Press Institute Teams with Newsela to Make Kids Savvier News Consumers

Web technologies have brought financial challenges and a tidal wave of media competitors to traditional news organizations in recent decades. Now a non-profit that has been championing newspapers since 1946 is using technology to bolster demand for high-quality journalism. The American Press Institute is working with educational technology company Newsela to teach school children how … Continue reading “Press Institute Teams with Newsela to Make Kids Savvier News Consumers”

Third-Quarter Report Shows Slowdown in VC Activity, & Top 10 Deals

Venture capital activity is gradually easing from last year’s peak, according to a new quarterly report put together by Seattle-based PitchBook and the National Venture Capital Association. VC firms invested $14.99 billion in 1,810 U.S. deals (1,796 companies) during the third quarter that ended September 30, according to the inaugural “Venture Monitor” report released today. … Continue reading “Third-Quarter Report Shows Slowdown in VC Activity, & Top 10 Deals”

Wine n Dine Receives $2,500,000 Seed Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6d527758-44e8-4c91-b45d-1280a7ab3423 Date 10/6/2016 Company Name Wine n Dine Mailing Address Undisclosed New York, NY 11001 USA Company Description Wine ‘n Dine is a service that allows consumers to quickly and easily find places to eat. It is an Instagram-style app that allows users follow other users in their area to see what … Continue reading “Wine n Dine Receives $2,500,000 Seed Funding Round”

OpenGamma Obtains $13,300,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7ca89eed-bcb9-45ae-8d3a-4fb185dde5a5 Date 10/6/2016 Company Name OpenGamma Mailing Address 125 Park Avenue 25th Floor New York, NY 10017 USA Company Description OpenGamma is a leading provider of risk analytics for the derivatives markets. The firm is a pioneer in open source financial software, and in 2016 released an award-winning derivatives analytics library for … Continue reading “OpenGamma Obtains $13,300,000 New Funding”

Eight Sleep Garners $10,446,621 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9e8c8c72-d41c-456b-99bf-52339e133ad6 Date 10/6/2016 Company Name Eight Sleep Mailing Address 146 Duane Street New York, NY 10013 USA Company Description A smart mattress cover that tracks sleep patterns, regulates temperature, and records disturbances to help you listen to your body better, and cut out things that make you wake. Designed, tested, and made … Continue reading “Eight Sleep Garners $10,446,621 New Financing”

Slice Labs Garners New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3a0f9785-4396-447b-8470-5f33d357e6e5 Date 10/6/2016 Company Name Slice Labs Mailing Address 340 Madison Ave. New York, NY 10173 USA Company Description Traditional coverage does not take into account that you are a person and a business. Slice does. Only pay for the coverage when you are participating in the on-demand world. Insurance that turns … Continue reading “Slice Labs Garners New Funding”

Ollie Pets Lands $4,400,000 Seed Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=425703d9-9bc6-4c65-8863-6a2524ae8699 Date 10/6/2016 Company Name Ollie Pets Mailing Address Undisclosed Brooklyn, NY 11234 USA Company Description We are on a mission to help pet parents provide happier, healthier, longer lives for their fur family. We are pet parents that explore and present expert information and science-based tips for healthy living with a … Continue reading “Ollie Pets Lands $4,400,000 Seed Round”